Caricamento...
Generation of Recombinant SARS‐CoV‐2 Using a Bacterial Artificial Chromosome
SARS‐CoV‐2, the causative agent of COVID‐19, has been responsible for a million deaths worldwide as of September 2020. At the time of this writing, there are no available US FDA−approved therapeutics for the treatment of SARS‐CoV‐2 infection. Here, we describe a detailed protocol to generate recombi...
Salvato in:
| Pubblicato in: | Curr Protoc Microbiol |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
John Wiley and Sons Inc.
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7646048/ https://ncbi.nlm.nih.gov/pubmed/33048448 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cpmc.126 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|